Kimyrsa

Product NDC
70842-225
11-digit product format
708420225
Labeler code
70842
Product ID
70842-225_25ae2ae5-afce-4475-bf3c-45323e93a952
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
oritavancin diphosphate
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Labeler
Melinta Therapeutics, LLC
Application
NDA214155
Marketing category
NDA
Marketing start
2021-03-23
Substance
ORITAVANCIN DIPHOSPHATE
Active strength
1200 mg/40mL
Pharmacologic classes
Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Lipoglycopeptide Antibacterial [EPC], Lipoglycopeptides [CS]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Kimyrsa
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
ORITAVANCIN DIPHOSPHATE1200 mg/40mL

Harmonized Identifiers#

Field, Values table
FieldValues
UniiVL1P93MKZN
Rxcui2532361, 2532366

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
379b20c4-7e52-4276-8a8d-fc6efc44abd4Product name120210903
8b844746-3ad0-4fdc-869e-bb322f11fbbaProduct name120141209

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
70842-225-01Kimyrsa40 mL in 1 VIALINJECTION, POWDER, LYOPHILIZED,407
70842-225-01Kimyrsa1 in 1 CARTONINJECTION, POWDER, LYOPHILIZED,17

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
70842-225-01EA - Each70842-2250d9077a6-8fb5-48b3-a1a0-e3f0a996481612021-06-02

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
70842-225KIMYRSA (ORITAVANCIN DIPHOSPHATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [MELINTA THERAPEUTICS, LLC]6Current NDC, Legacy NDC, 2 package rows20250508_5e755c40-6e73-4572-b474-4d8a131693d1.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
2532366Kimyrsa 1200 MG InjectionPSN5e755c40-6e73-4572-b474-4d8a131693d17
2532361oritavancin 1200 MG InjectionPSN5e755c40-6e73-4572-b474-4d8a131693d17
2532366oritavancin 1200 MG Injection [Kimyrsa]SBD5e755c40-6e73-4572-b474-4d8a131693d17
2532361oritavancin 1200 MG InjectionSCD5e755c40-6e73-4572-b474-4d8a131693d17
2532366Kimyrsa 1200 MG (as oritavancin diphosphate 1331.16 MG) InjectionSY5e755c40-6e73-4572-b474-4d8a131693d17
2532366Kimyrsa 1200 MG InjectionSY5e755c40-6e73-4572-b474-4d8a131693d17
2532361oritavancin 1200 MG (as oritavancin diphosphate 1331.16 MG) InjectionSY5e755c40-6e73-4572-b474-4d8a131693d17

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
70842-225-01708420225011 VIAL in 1 CARTON (70842-225-01) / 40 mL in 1 VIAL1 vial2021-03-230000-00-00NoNoCurrent